Table 1.
Items | L Group | M Group | H Group |
---|---|---|---|
N (Male/Female) | 55 (37/18) | 90 (56/34) | 50 (36/14) |
Age (Yrs) | 54.09 ± 9.73 | 50.68 ± 9.98a* | 48.40 ± 9.08a** |
BMI | 25.47 ± 2.91 | 25.34 ± 2.88 | 24.19 ± 3.11a* |
HbA1c (%) | 7.60 ± 0.32 | 9.13 ± 0.53 | 11.55 ± 1.36 |
Bg 0 (mmol/L) | 8.53 ± 1.66 | 10.09 ± 1.78a** | 12.40 ± 2.24ab** |
Bg 30 (mmol/L) | 14.69 ± 2.46 | 15.59 ± 2.43 | 18.16 ± 3.41ab** |
Bg 120 (mmol/L) | 18.47 ± 3.43 | 21.50 ± 3.75a* | 24.51 ± 4.58ab* |
Cp 0 (pmol/L) | 2.58 ± 0.90 | 2.42 ± 0.82 | 1.81 ± 0.58ab* |
Cp 30 (pmol/L) | 4.40 ± 2.15 | 3.54 ± 1.59a* | 2.50 ± 1.11ab* |
Cp 120 (pmol/L) | 8.10 ± 2.51 | 5.74 ± 2.02a* | 3.72 ± 1.52ab* |
Ins 0 (mU/L) | 8.97 ± 4.85 | 8.06 ± 4.75a* | 4.84 ± 2.26ab* |
Ins 30 (mU/L) | 24.07 ± 17.25 | 18.04 ± 15.69 | 8.44 ± 4.87ab* |
Ins 120 (mU/L) | 48.50 ± 26.40 | 28.03 ± 17.63a* | 14.72 ± 10.08ab* |
HOMA-IR | 3.42 ± 1.87 | 3.69 ± 2.35 | 2.58 ± 1.15ab* |
Matsuda Index | 85.04 ± 75.47 | 94.63 ± 71.63 | 125.88 ± 59.67ab* |
HOMA-B | 37.81 ± 23.88 | 25.46 ± 15.90a** | 12.01 ± 6.81ab** |
Data are presented as the means ± SD. L group: Lower HbA1c values group, M group: Moderate HbA1c values group, H group: higher HbA1c values group, a*compared with the L Group (P < 0.05), a**compared with M Group (P < 0.01), b*compared with M Group (P < 0.05), b**compared with M Group (P < 0.01), Bg 0: blood glucose concentrations before glucose loading, Bg 30: blood glucose concentrations at 30 min after glucose loading, Bg 120: blood glucose concentrations at 120 min after glucose loading, Cp 0: serum C-Peptide concentrations before glucose loading, Cp 30: serum C-Peptide concentrations 30 min after glucose loading, Cp 120: serum C-Peptide concentrations 120 min after glucose loading, Ins 0: serum insulin concentrations before glucose loading, Ins 30: serum insulin concentrations 30 min after glucose loading, Ins 120: serum insulin concentrations 120 min after glucose loading.